Follow the people · Insider
Leonard E. Post
Leonard E. Post files insider transactions with the SEC as a director of CG Oncology (CGON). We hold 6 disclosed purchases and sales filed since 8 February 2007, 5 of them in the last 90 days.
- Files forCGON
- Disclosed buys and sells6 in all, 5 in the last 90 days
- Last disclosure18 August 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 4 October 2024 — 14 August 2026Director · CG Oncology (CGON)58 Form 4 lines · source: SEC Form 4
- Filed 15 September 2020 — 11 June 2026Director · uniQure (QURE)21 Form 4 lines · source: SEC Form 4
- Filed 1 August 2022 — 1 August 2022Director · Fulgent Genetics (FLGT)1 Form 4 line · source: SEC Form 4
- Filed 7 February 2007 — 7 February 2007Director · Praecis Pharmaceuticals (PRCS)1 Form 4 line · source: SEC Form 4
Everything they disclosed
81 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 1,000 shares of CG OncologySEC Form 418 August 2026Common Stock · traded 14 August 2026 · filed 18 August 2026
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 418 August 2026Common Stock · traded 14 August 2026 · filed 18 August 2026
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 418 August 2026Director Stock Option (right to buy) · traded 14 August 2026 · filed 18 August 2026
- exercised options over 1,000 shares of CG OncologySEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 417 July 2026Director Stock Option (right to buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 5,000 shares of CG OncologySEC Form 425 June 2026Common Stock · traded 24 June 2026 · filed 25 June 2026
- ▼ sold on the open market 5,000 shares of CG OncologySEC Form 425 June 2026Common Stock · traded 24 June 2026 · filed 25 June 2026
- exercised options over 5,000 shares of CG Oncology (a derivative holding)SEC Form 425 June 2026Director Stock Option (right to buy) · traded 24 June 2026 · filed 25 June 2026
- exercised options over 5,000 shares of CG OncologySEC Form 423 June 2026Common Stock · traded 22 June 2026 · filed 23 June 2026
- ▼ sold on the open market 5,000 shares of CG OncologySEC Form 423 June 2026Common Stock · traded 22 June 2026 · filed 23 June 2026
- exercised options over 5,000 shares of CG Oncology (a derivative holding)SEC Form 423 June 2026Director Stock Option (right to buy) · traded 22 June 2026 · filed 23 June 2026
- was granted 7,550 shares of uniQureSEC Form 412 June 2026Ordinary Shares · traded 10 June 2026 · filed 12 June 2026
- ▼ sold on the open market 1,993 shares of uniQureSEC Form 412 June 2026Ordinary Shares · traded 11 June 2026 · filed 12 June 2026
- was granted 13,980 shares of uniQure (a derivative holding)SEC Form 412 June 2026Stock Option (Right to Buy) · traded 10 June 2026 · filed 12 June 2026
- exercised options over 1,000 shares of CG OncologySEC Form 45 June 2026Common Stock · traded 4 June 2026 · filed 5 June 2026
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 45 June 2026Common Stock · traded 4 June 2026 · filed 5 June 2026
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 45 June 2026Director Stock Option (right to buy) · traded 4 June 2026 · filed 5 June 2026
- was granted 9,354 shares of CG Oncology (a derivative holding)SEC Form 45 June 2026Director Stock Option (right to buy) · traded 4 June 2026 · filed 5 June 2026
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 418 November 2025Director Stock Option (right to buy) · traded 17 November 2025 · filed 18 November 2025
- exercised options over 1,000 shares of CG OncologySEC Form 418 November 2025Common Stock · traded 17 November 2025 · filed 18 November 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 418 November 2025Common Stock · traded 17 November 2025 · filed 18 November 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 415 October 2025Director Stock Option (right to buy) · traded 13 October 2025 · filed 15 October 2025
- exercised options over 1,000 shares of CG OncologySEC Form 415 October 2025Common Stock · traded 13 October 2025 · filed 15 October 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 415 October 2025Common Stock · traded 13 October 2025 · filed 15 October 2025
- exercised options over 5,000 shares of CG Oncology (a derivative holding)SEC Form 41 October 2025Director Stock Option (right to buy) · traded 30 September 2025 · filed 1 October 2025
- exercised options over 5,000 shares of CG OncologySEC Form 41 October 2025Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 5,000 shares of CG OncologySEC Form 41 October 2025Common Stock · traded 30 September 2025 · filed 1 October 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 416 September 2025Director Stock Option (right to buy) · traded 15 September 2025 · filed 16 September 2025
- exercised options over 1,000 shares of CG OncologySEC Form 416 September 2025Common Stock · traded 15 September 2025 · filed 16 September 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 416 September 2025Common Stock · traded 15 September 2025 · filed 16 September 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 44 September 2025Director Stock Option (right to buy) · traded 3 September 2025 · filed 4 September 2025
- exercised options over 1,000 shares of CG OncologySEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- exercised options over 2,000 shares of CG Oncology (a derivative holding)SEC Form 418 July 2025Director Stock Option (right to buy) · traded 17 July 2025 · filed 18 July 2025
- exercised options over 2,000 shares of CG OncologySEC Form 418 July 2025Common Stock · traded 17 July 2025 · filed 18 July 2025
- ▼ sold on the open market 2,000 shares of CG OncologySEC Form 418 July 2025Common Stock · traded 17 July 2025 · filed 18 July 2025
- ▼ sold on the open market 2,112 shares of uniQureSEC Form 424 June 2025Ordinary Shares · traded 20 June 2025 · filed 24 June 2025
- was granted 15,630 shares of uniQure (a derivative holding)SEC Form 413 June 2025Stock Option (Right to Buy) · traded 11 June 2025 · filed 13 June 2025
- was granted 7,970 shares of uniQureSEC Form 413 June 2025Ordinary Shares · traded 11 June 2025 · filed 13 June 2025
- was granted 24,165 shares of CG Oncology (a derivative holding)SEC Form 46 June 2025Director Stock Option (right to buy) · traded 5 June 2025 · filed 6 June 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 422 May 2025Director Stock Option (right to buy) · traded 21 May 2025 · filed 22 May 2025
- exercised options over 1,000 shares of CG OncologySEC Form 422 May 2025Common Stock · traded 21 May 2025 · filed 22 May 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 422 May 2025Common Stock · traded 21 May 2025 · filed 22 May 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 429 April 2025Director Stock Option (right to buy) · traded 28 April 2025 · filed 29 April 2025
- exercised options over 1,000 shares of CG OncologySEC Form 429 April 2025Common Stock · traded 28 April 2025 · filed 29 April 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 429 April 2025Common Stock · traded 28 April 2025 · filed 29 April 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 418 March 2025Director Stock Option (right to buy) · traded 17 March 2025 · filed 18 March 2025
- exercised options over 1,000 shares of CG OncologySEC Form 418 March 2025Common Stock · traded 17 March 2025 · filed 18 March 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 418 March 2025Common Stock · traded 17 March 2025 · filed 18 March 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 419 February 2025Director Stock Option (right to buy) · traded 18 February 2025 · filed 19 February 2025
- exercised options over 1,000 shares of CG OncologySEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 414 January 2025Director Stock Option (right to buy) · traded 13 January 2025 · filed 14 January 2025
- exercised options over 1,000 shares of CG OncologySEC Form 414 January 2025Common Stock · traded 13 January 2025 · filed 14 January 2025
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 414 January 2025Common Stock · traded 13 January 2025 · filed 14 January 2025
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 417 December 2024Stock Option · traded 16 December 2024 · filed 17 December 2024
- exercised options over 1,000 shares of CG OncologySEC Form 417 December 2024Common Stock · traded 16 December 2024 · filed 17 December 2024
- ▼ sold on the open market 1,000 shares of CG OncologySEC Form 417 December 2024Common Stock · traded 16 December 2024 · filed 17 December 2024
- exercised options over 1,000 shares of CG Oncology (a derivative holding)SEC Form 46 December 2024Stock Option · traded 6 December 2024 · filed 6 December 2024
- exercised options over 1,000 shares of CG OncologySEC Form 46 December 2024Common Stock · traded 6 December 2024 · filed 6 December 2024
- ▼ sold on the open market 750 shares of CG OncologySEC Form 46 December 2024Common Stock · traded 6 December 2024 · filed 6 December 2024
- ▼ sold on the open market 250 shares of CG OncologySEC Form 46 December 2024Common Stock · traded 6 December 2024 · filed 6 December 2024
- was granted 15,600 shares of CG Oncology (a derivative holding)SEC Form 47 October 2024Stock Option (Right to Buy) · traded 4 October 2024 · filed 7 October 2024
- was granted 15,840 shares of uniQure (a derivative holding)SEC Form 421 June 2024Stock Option (Right to Buy) · traded 19 June 2024 · filed 21 June 2024
- was granted 8,080 shares of uniQureSEC Form 421 June 2024Ordinary Shares · traded 19 June 2024 · filed 21 June 2024
- ▼ sold on the open market 2,222 shares of uniQureSEC Form 418 June 2024Ordinary Shares · traded 13 June 2024 · filed 18 June 2024
- was granted 17,060 shares of uniQure (a derivative holding)SEC Form 420 June 2023Stock Option (Right to Buy) · traded 13 June 2023 · filed 20 June 2023
- was granted 8,700 shares of uniQureSEC Form 420 June 2023Ordinary Shares · traded 13 June 2023 · filed 20 June 2023
- ▼ sold on the open market 2,291 shares of uniQureSEC Form 420 June 2023Ordinary Shares · traded 16 June 2023 · filed 20 June 2023
- ▼ sold on the open market 389 shares of uniQureSEC Form 41 March 2023Ordinary Shares · traded 27 February 2023 · filed 1 March 2023
- was granted 8,000 shares of Fulgent GeneticsSEC Form 43 August 2022Common Stock · traded 1 August 2022 · filed 3 August 2022
- was granted 17,810 shares of uniQure (a derivative holding)SEC Form 417 June 2022Stock Option (Right to Buy) · traded 15 June 2022 · filed 17 June 2022
- was granted 9,080 shares of uniQureSEC Form 417 June 2022Ordinary Shares · traded 15 June 2022 · filed 17 June 2022
- ▼ sold on the open market 795 shares of uniQureSEC Form 42 March 2022Ordinary Shares · traded 28 February 2022 · filed 2 March 2022
- was granted 2,645 shares of uniQure (a derivative holding)SEC Form 428 February 2022Stock Option (Right to Buy) · traded 24 February 2022 · filed 28 February 2022
- was granted 1,534 shares of uniQureSEC Form 428 February 2022Ordinary Shares · traded 24 February 2022 · filed 28 February 2022
- was granted 2,382 shares of uniQureSEC Form 41 March 2021Ordinary Shares · traded 25 February 2021 · filed 1 March 2021
- was granted 4,107 shares of uniQure (a derivative holding)SEC Form 41 March 2021Stock Option (Right to Buy) · traded 25 February 2021 · filed 1 March 2021
- was granted 10,000 shares of uniQure (a derivative holding)SEC Form 417 September 2020Stock option (Right to Buy) · traded 15 September 2020 · filed 17 September 2020
- returned to the issuer 4,000 shares of Praecis Pharmaceuticals (a derivative holding)SEC Form 48 February 2007Stock Option (Right to Buy) · traded 7 February 2007 · filed 8 February 2007
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.